OrbiMed’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15.5M | Buy |
1,196,955
+603,867
| +102% | +$7.81M | 0.39% | 48 |
|
2025
Q1 | $4.6M | Sell |
593,088
-6,912
| -1% | -$53.6K | 0.11% | 76 |
|
2024
Q4 | $13.6M | Buy |
+600,000
| New | +$13.6M | 0.28% | 64 |
|
2021
Q2 | – | Sell |
-6,387
| Closed | -$5.47M | – | 162 |
|
2021
Q1 | $5.47M | Buy |
6,387
+2,699
| +73% | +$2.31M | 0.05% | 139 |
|
2020
Q4 | $3.36M | Sell |
3,688
-9,931
| -73% | -$9.04M | 0.03% | 141 |
|
2020
Q3 | $16.5M | Sell |
13,619
-24,394
| -64% | -$29.6M | 0.21% | 93 |
|
2020
Q2 | $13.9M | Buy |
+38,013
| New | +$13.9M | 0.2% | 88 |
|